100 related articles for article (PubMed ID: 2272174)
1. The role of ras gene mutations in myeloproliferative disorders.
Liu ET
Clin Lab Med; 1990 Dec; 10(4):797-807. PubMed ID: 2272174
[TBL] [Abstract][Full Text] [Related]
2. N-ras and p53 gene mutations in Japanese patients with myeloproliferative disorders.
Tsurumi S; Nakamura Y; Maki K; Omine M; Fujita K; Okamura T; Niho Y; Hashimoto S; Kanno K; Suzuki K; Hangaishi A; Ogawa S; Hirai H; Mitani K
Am J Hematol; 2002 Oct; 71(2):131-3. PubMed ID: 12353315
[TBL] [Abstract][Full Text] [Related]
3. Mutations in ras genes in myelocytic leukemias and myelodysplastic syndromes.
Bartram CR
Blood Cells; 1988; 14(2-3):533-8. PubMed ID: 3067784
[TBL] [Abstract][Full Text] [Related]
4. Analysis of ras gene mutations and methylation state in human leukemias.
Browett PJ; Norton JD
Oncogene; 1989 Aug; 4(8):1029-36. PubMed ID: 2668844
[TBL] [Abstract][Full Text] [Related]
5. N-RAS activation in the terminal stage of undifferentiated chronic myeloproliferative disease.
Inokuchi K; Futaki M; Miyake K; Kuwabara T; Shinohara T; Dan K; Nomura T
Int J Hematol; 1992 Aug; 56(1):9-15. PubMed ID: 1391809
[TBL] [Abstract][Full Text] [Related]
6. Rapid mutational analysis of N-ras proto-oncogene in hematologic malignancies: study of 77 Greek patient.
Speletas M; Arvanitidi K; Tzoanopoulos D; Tsironidou V; Pardali E; Aggeli C; Tsapogas P; Kartalis G; Sideras P; Ritis K
Haematologica; 2001 Sep; 86(9):918-27. PubMed ID: 11532619
[TBL] [Abstract][Full Text] [Related]
7. Hypereosinophilic syndrome with evolution to myeloproliferative disorder: temporal relationship to loss of Y chromosome and c-N-ras activation.
Needleman SW; Mane SM; Gutheil JC; Kapil V; Heyman MR; Testa JR
Hematol Pathol; 1990; 4(3):149-55. PubMed ID: 2258361
[TBL] [Abstract][Full Text] [Related]
8. RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes.
Janssen JW; Steenvoorden AC; Lyons J; Anger B; Böhlke JU; Bos JL; Seliger H; Bartram CR
Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9228-32. PubMed ID: 3122217
[TBL] [Abstract][Full Text] [Related]
9. Ras gene mutations in patients with acute myeloid leukaemia and exposure to chemical agents.
Barletta E; Gorini G; Vineis P; Miligi L; Davico L; Mugnai G; Ciolli S; Leoni F; Bertini M; Matullo G; Costantini AS
Carcinogenesis; 2004 May; 25(5):749-55. PubMed ID: 14688017
[TBL] [Abstract][Full Text] [Related]
10. Mutant molecules of interest in myeloproliferative neoplasms: introduction.
Tefferi A
Acta Haematol; 2008; 119(4):192-3. PubMed ID: 18566535
[No Abstract] [Full Text] [Related]
11. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
[TBL] [Abstract][Full Text] [Related]
12. Genetics of myeloid malignancies: pathogenetic and clinical implications.
Fröhling S; Scholl C; Gilliland DG; Levine RL
J Clin Oncol; 2005 Sep; 23(26):6285-95. PubMed ID: 16155011
[TBL] [Abstract][Full Text] [Related]
13. N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation.
Shen S; Passioura T; Symonds G; Dolnikov A
Exp Hematol; 2007 Jun; 35(6):908-19. PubMed ID: 17533045
[TBL] [Abstract][Full Text] [Related]
14. ras mutations in human leukemia and related disorders.
Greenberger JS
Int J Cell Cloning; 1989 Nov; 7(6):343-59. PubMed ID: 2681441
[TBL] [Abstract][Full Text] [Related]
15. Mutations and promoter methylation status of NPM1 in myeloproliferative disorders.
Oki Y; Jelinek J; Beran M; Verstovsek S; Kantarjian HM; Issa JP
Haematologica; 2006 Aug; 91(8):1147-8. PubMed ID: 16870548
[TBL] [Abstract][Full Text] [Related]
16. p53 lesions in leukemic transformation.
Harutyunyan A; Klampfl T; Cazzola M; Kralovics R
N Engl J Med; 2011 Feb; 364(5):488-90. PubMed ID: 21288114
[No Abstract] [Full Text] [Related]
17. Prognostic significance of N-RAS and K-RAS mutations in 232 patients with acute myeloid leukemia.
Ritter M; Kim TD; Lisske P; Thiede C; Schaich M; Neubauer A
Haematologica; 2004 Nov; 89(11):1397-9. PubMed ID: 15531466
[TBL] [Abstract][Full Text] [Related]
18. [Molecular diagnosis of chronic myeloproliferative diseases and myelodysplastic syndromes].
Bock O
Verh Dtsch Ges Pathol; 2007; 91():140-53. PubMed ID: 18314608
[TBL] [Abstract][Full Text] [Related]
19. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
Bentires-Alj M; Paez JG; David FS; Keilhack H; Halmos B; Naoki K; Maris JM; Richardson A; Bardelli A; Sugarbaker DJ; Richards WG; Du J; Girard L; Minna JD; Loh ML; Fisher DE; Velculescu VE; Vogelstein B; Meyerson M; Sellers WR; Neel BG
Cancer Res; 2004 Dec; 64(24):8816-20. PubMed ID: 15604238
[TBL] [Abstract][Full Text] [Related]
20. The molecular biology of myeloproliferative disorders as revealed by chromosomal abnormalities.
Zeleznik-Le NJ; Nucifora G; Rowley JD
Semin Hematol; 1995 Jul; 32(3):201-19. PubMed ID: 7570064
[No Abstract] [Full Text] [Related]
[Next] [New Search]
